The FDA inspected and reviewed Warnex's bioanalytical laboratories and its quality control systems, as well as several client-specific studies, during the recent audit
Warnex reports the favourable outcome from an inspection of its facilities performed by the US Food and Drug Administration (FDA) and completed on 6 April 2007.
Warnex is compliant with FDA regulations and there were no major observations requiring any corrective action.
"We are pleased to have once again successfully passed an FDA audit.
"This achievement demonstrates the ongoing quality of our work at all levels of our organisation," said Mark Busgang, president and CEO of Warnex.
